Healthy Skepticism Library
Items published during the years 1990 to 1999
There are 2362 items in the Healthy Skepticism Library that were published during the years 1990 to 1999.
Page 22 of 24 pages ‹ First < 20 21 22 23 24 >
HSL9484
Brown SA.
Unscrambling the meaning of the Prescription Drug Marketing Act
Pharmaceutical Executive 1990 Nov; 10:68, 70, 72-73
HSL9494
Wertheimer AI.
Managed care pharmacy service.
Top Hosp Pharm Manage 1990 Nov; 10:(3):1-7
HSL1873
McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich EC.
Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives.
JAMA 1990 Oct 3; 264:(13):1693-7
HSL4095
Rennie D, Bero LA.
Throw it away, Sam: the controlled circulation journals.
AJR Am J Roentgenol 1990 Oct; 155:(4):889-92
HSL4153
Kawachi I.
Codes of advertising practice of the pharmaceutical industry: in New Zealand and other countries
1990 Oct
HSL4157
MaLAM Letter follow up—Wellcome, Nicholas and Sterling have not yet provided any evidence to support their claims
MaLAM Newsletter 1990 Oct
HSL4158
Wilson GJ.
Training sales reps 1990s style
Medical Marketing & Media 1990 Oct; 25:(10):16-18, 20, 23-24, 26, 28
HSL4289
Dumont MP.
In bed together at the market: psychiatry and the pharmaceutical industry.
Am J Orthopsychiatry 1990 Oct; 60:(4):484-5
HSL9479
Oladimeji FA, Iranloye TA
Pharmacy World Journal 1990 Oct-Dec; 7:123-128
HSL9491
McCarthy R.
Third-party pharmacy: year of new perspectives
National Association of Retail Druggists Journal 1990 Oct; 112:56-59
HSL9492
Law with no enforcer: HHS turns its back on drug diversion
National Association of Retail Druggists Journal 1990 Oct; 112:18-21
HSL19902
Cohen S
Drug donations to Sudan [letter]
Lancet 1990 Sep 22; 336:(8717):745
http://www.lancet.com/journals/lancet/article/PII0140-6736%2890%2992233-8/fulltext
HSL4092
Rapp MS.
A sample argument.
CMAJ 1990 Sep 15; 143:(6):467-8
HSL4128
Watters WW.
Hypertension and eating habits.
CMAJ 1990 Sep 15; 143:(6):460-1
HSL9497
Hardisty B.
Enigma of OTC advertising
Pharmaceutical Journal 1990 Sep 15; 245:321
HSL5756
Kilbourne WE.
Perceptual biases in affirmative disclosures in print ads: Practical and public policy implications
Journal of Business Research 1990 Sep 1; 21:(2):131-141
HSL9489
Hardisty B.
NHS and Community Care Act 1990: effects on the industry
Pharmaceutical Journal 1990 Sep 1; 245:273-275
HSL4150
Re: the promotion of neomycin/kaolin/pectin
1990 Sep
HSL4154
Kawachi I.
Pharmaceutical advertising and promotion—options for action
1990 Sep
HSL4155
Peacock S.
Two surveys of pharmaceutical promotion and advertising
1990 Sep
HSL4156
Saade C, Huff-Rousselle M.
Pakistan: Should ORS be marketed like other drugs?
Dialogue on Diarrhoea 1990 Sep; (42):6
HSL9487
Spalding BJ.
Generic industry: one year later
American Druggist 1990 Sep; 202:14, 16
HSL9496
Martin S.
Overhauling Medicaid.
Am Pharm 1990 Sep; NS30:(9):25-7
HSL4089
Perman E.
Voluntary control of drug promotion in Sweden.
N Engl J Med 1990 Aug 30; 323:(9):616-7
HSL4054
Use of drugs in childhood: a preliminary study in Malaysia
Education and Research Association for Consumer (ERA Consumer) 1990 Aug 12-16;
HSL4083
Nelson JC.
A piece of my mind. A snorkel, a 5-iron, and a pen
JAMA. 1990 Aug 8;264(6):742 1990 Aug 08; 264:(6):742
HSL4149
Re: the promotion of phenazone/brompheniramine/quinine/caffeine/salicylamide
1990 Aug
HSL9495
Concerning the case of United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association
American Pharmacy 1990 Aug; 55-57
HSL9498
Pharmacist at the top: Syntex's Freiman comments on pharmacy's role
American Druggist 1990 Aug; 202:77-78
HSL4105
Schonberg SE.
Relations between physicians and pharmaceutical companies; where to draw the line.
N Engl J Med 1990 Jul 19; 323:(3):200-1
HSL4107
Schonhofer PS.
Litigation and criticisms about drugs.
Lancet 1990 Jul 14; 336:(8707):120
HSL4148
Conti CR, Williams JF Jr, Anderson JL, Berman HA, Gunnar RM, Herman GP, Lyons FW Jr, Passamani ER, Reid PR, Silverman ME, et al.
Ethics in cardiovascular medicine Task Force V: The relation of cardiovascular specialists to industry, institutions and organizations
Journal of the American College of Cardiologists 1990 Jul 01; 16:(1):30-33
HSL1845
Ferguson RP.
Teaching medical residents critical analysis of pharmaceutical promotional material.
Del Med J 1990 Jul; 62:(7):1127-9
HSL9499
Behling L.
Curing Medicaid's ills: two plans propose to do just that
Massachusetts Pharmacist 1990 Jul-Aug; 2:10-11
HSL4032
Beck M.
Horse chestnut seed extract.
Lancet 1990 Jun 16; 335:(8703):1467
HSL4120
Thomson A.
For the price of a pen!
N Z Med J. 1990 Jun 13; 103:(891):278-9
HSL4146
As advertised on TV
Economist 1990 Jun 9; 68
HSL4061
Gordon M.
Disinformation from pharmaceutical company representatives.
CMAJ 1990 Jun 1; 142:(11):1177-8
HSL4102
Santell JP, Birdwell SW, Scheckelhoff DJ.
Perception of the role of medical-service representatives in hospitals.
Am J Hosp Pharm 1990 Jun; 47:(6):1354-9
HSL4143
Re: the promotion of glafenine
1990 Jun
HSL4144
Undue influence: how drug companies sway doctors’ decisions
Consumer Food & Health 1990 Jun7-9
HSL4147
Re: the promotion of loperamide for children
1990 Jun
HSL9500
Mosso J.
Prescription pricing: pharmacy perspective
National Association of Retail Druggists Journal 1990 Jun; 112:20-23
HSL9501
Major pharmaceutical manufacturer supports Medicaid equal access
National Association of Retail Druggists Journal 1990 Jun; 112:59-60
HSL9503
Teagarden JR, Hubler GL.
Corporate patient management system
Hospital Pharmacy 1990 Jun; 25:520, 526
HSL13293
Maheswaranand D, Sternthal B.
The Effects of Knowledge, Motivation, and Type of Message on Ad Processing and Product Judgments
Journal of Consumer Research 1990 Jun; 17:(1):66-73
http://www.journals.uchicago.edu/action/jstor?sici=0093-5301%28199006%2917%3A1%3C66%3ATEOKMA%3E2.0.CO%3B2-C&doi=10.1086%2F208537
HSL4121
Tietze KJ, Smith MC.
More on sex and racial bias in pharmaceutical advertisements.
N Engl J Med 1990 May 24; 322:(21):1534
HSL4051
[No authors listed] Related Articles, Links
Conflicts of interest in medical center/industry research relationships.
Council on Scientific Affairs and Council on Ethical and Judicial Affairs.
JAMA 1990 May 23-30; 263:(20):2790-3
HSL4077
McLauchlan B.
For the price of a pen.
N Z Med J 1990 May 23; 103:(890):250
HSL1874
Lurie N, Rich EC, Simpson DE, Meyer J, Schiedermayer DL, Goodman JL, McKinney WP.
Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff.
J Gen Intern Med 1990 May-Jun; 5:(3):240-3
http://www.ncbi.nlm.nih.gov/pubmed/2341925
HSL4112
Smeeding JE.
Direct-to-consumer advertising of prescription pharmaceuticals: strategic issues for the pharmaceutical industry.
Top Hosp Pharm Manage 1990 May; 10:(1):40-64
HSL4142
Sweeney GD.
A submission to the College of Physicians & Surgeons of Ontario on the relationship between the faculty and the Canadian pharmaceutical industry
1990 May
HSL9502
Getting a grip on Medicaid costs
National Association of Retail Druggists Journal 1990 May; 112:32-35
HSL9504
Prescription-to-nonprescription switches to be dominant force in nonprescription market
American Journal of Hospital Pharmacy 1990 May; 47:960
HSL9505
Lederle to donate cefixime to homeless persons through community health centers
American Journal of Hospital Pharmacy 1990 May; 47:964
HSL9507
Sesti LM.
Concerning the case of: United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association, Civil No. G75-558 CA5, W. D. Michigan
Journal Michigan Pharmacist 1990 May; 28:170-171
HSL9508
Klepcyk JC.
Marketing a discharge prescriptions program
American Journal of Hospital Pharmacy 1990 May; 47:1006
HSL4081
Murdoch JC.
For the price of a pen!
N Z Med J. 1990 Apr 25; 103:(888):190
HSL4117
Steinbrook R, Lo B.
Informing physicians about promising new treatments for severe illnesses.
JAMA 1990 Apr 18; 263:(15):2078-82
HSL4028
Physicians and the pharmaceutical industry.
Ann Intern Med 1990 Apr 15; 112:(8):624-6
HSL4141
Mansfield PR.
1990 Apr 9
HSL3699
US General Accounting Office.
FDA drug review. Postapproval risks 1976-1985. Report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations.
Washington DC.: Committee on Government Operations. 1990 Apr
HSL4139
MaLAM Letter follow up—were “brain tonic” results just a stroke of luck?
MaLAM Newsletter 1990 Apr
HSL4140
Re: the promotion of sulbutiamine
1990 Apr
HSL9506
McCarthy R.
Triplicate prescriptions: benzodiazepines
American Druggist 1990 Apr; 201:64-66, 68, 70
HSL4106
Schonhofer PS.
Ginkgo biloba extracts.
Lancet 1990 Mar 31; 335:(8692):788
HSL4138
A review of attitudes, impressions, problems, restraints and policies existing regarding the present process of government control over drug advertising in Canada
1990 Mar 15
HSL4108
McCarthy M, Aarons D, Scott HV.
Cefixime: in vitro sensitivity of respiratory and urinary tract infection organisms.
N Z Med J 1990 Mar 14; 103:(885):106
HSL9162
Bradley C, Blenkinsopp A.
Over the counter drugs: The future for self medication
BMJ 1996 Mar 9; 312:629-632
http://www.bmj.com/cgi/content/full/312/7034/835
HSL1875
Caplan RM.
CME ethics, continued.
Iowa Med 1990 Mar; 80:(3):135
HSL4132
MaLAM letter follow up—FCE admit data sheet was obsolete
MaLAM Newsletter 1990 Mar; 2
HSL4133
MaLAM letter follow up—Uteplex withdrawn except in Europe
MaLAM Newsletter 1990 Mar;
HSL4134
Re: the promotion of Aspro for children
1990 Mar
HSL4135
Direct-to-consumer advertising becoming more accepted
Medical Marketing & Media 1990 Mar; 25:(3):64
HSL4151
Boyd B.
What you see depends on where you sit: Department of Health perspective
1990 Mar
HSL4152
Durham J.
Pharmaceutical promotion in New Zealand—a view from general practice
1990 Mar
HSL16655
Connelly DP, Rich EC, Curley SP, Kelly JT.
Knowledge resource preferences of family physicians.
J Fam Pract 1990 Mar; 30:(3):353-9
http://www.ncbi.nlm.nih.gov/pubmed/2248632
HSL4069
Jenike MA.
Relations between physicians and pharmaceutical companies: where to draw the line.
N Engl J Med 1990 Feb 22; 322:(8):557
HSL4030
Anderton D.
Advertising acyclovir.
Lancet 1990 Feb 3; 335:(8684):288
HSL4066
Herxheimer A, Collier J.
Promotion by the British pharmaceutical industry, 1983-8: a critical analysis of self regulation.
BMJ 1990 Feb 3; 300:(6720):307-11
HSL4104
Schiff G.
Persantine advertisement: artistic license or misleading implication?
JAMA 1990 Feb 2; 263:(5):658-9
HSL9511
Senate studies how private sector negotiates with pharmaceutical manufacturers for lower prices
American Pharmacy 1990 Feb; 8
HSL9512
Smith JM.
Information on unlicensed products
British Journal of Pharmaceutical Practice 1990 Feb; 12:39
HSL9513
Leblang TR.
Defective Rx drugs
American Druggist 1990 Feb; 201:50
HSL20488
Miller C
Doctors hit drug firms over ads
The Herald and Weeky Times 1990 Jan 31
HSL20180
Brahams D
Medicine and The Law
The Lancet 1990 Jan 20; 335:(8682):157
http://www.lancet.com/journals/lancet/article/PII0140-6736%2890%2990019-2/fulltext
HSL4045
Campbell B.
Throw-away journals: tactics for dealing with office waste
CMAJ 1990 Jan 15; 142:(2):100
HSL4064
Harvey K.
Pharmaceutical promotion.
Med J Aust 1990 Jan 15; 152:(2):57-8
HSL4101
Salem AG.
Medical education and the pharmaceutical industry.
J Gen Intern Med 1990 Jan-Feb; 5:(1):91-2
HSL9510
Third parties could help pharmacy
American Druggist 1990 Jan; 201:12
HSL9515
Human side of rising drug prices
National Association of Retail Druggists Journal 1990 Jan; 112:20-23
HSL4025
Consumer information
Lancet 1990; (335):1395
HSL4026
MaLAM replies to IFPMA letter
Scrip 1990; (1523):26
HSL4027
Ahmad SR, Bhutta ZA.
A survey of pediatric prescribing and dispensing in Karachi
Journal of the Pakistan Medical Association 1990; 40:126-130
HSL4029
American Federation for Clinical Research Guidelines for Avoiding Conflict of Interest
Clinical Research 1990; 38:239-240
HSL4031
Andrew M.
Ethical guidelines for promotion of prescription drugs to physicians
New England Journal of Medicine 1990; 322:65
HSL4034
Berry J.
Doctors, drug companies, and gifts
JAMA 1990; 263:2178
HSL4035
Berube B.
Marketing ibuprofen
Canadian Pharmaceutical Journal 1990; 123:402
HSL4036
Berube B.
The slick sell: the pharmacist’s view
Canadian Pharmaceutical Journal 1990; 123:400-401
HSL4037
Berube B.
The subtle sell: an overview
Canadian Pharmaceutical Journal 1990; 123:397-398
Page 22 of 24 pages ‹ First < 20 21 22 23 24 >
